Immediate Impact
67 standout
Citing Papers
Mapping the effectiveness and risks of GLP-1 receptor agonists
2025 Standout
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
2025 Standout
Works of David Nathanson being referenced
Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013
2016
Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| David Nathanson | 187 | 203 | 75 | 90 | 22 | 477 | |
| Takashi Iguchi | 173 | 127 | 87 | 60 | 26 | 512 | |
| Amy H. Stanford | 112 | 108 | 71 | 46 | 21 | 431 | |
| Steffy W. M. Jansen | 64 | 201 | 32 | 53 | 24 | 503 | |
| Jonas Sode | 71 | 109 | 119 | 78 | 46 | 443 | |
| Caner Karahan | 67 | 87 | 99 | 74 | 20 | 541 | |
| Sia Kromann Nicolaisen | 171 | 162 | 48 | 41 | 29 | 557 | |
| S. Sans | 53 | 158 | 108 | 50 | 14 | 531 | |
| Kerstin Bettermann | 38 | 101 | 105 | 80 | 18 | 524 | |
| Xinhua Hu | 97 | 109 | 107 | 36 | 30 | 563 | |
| S Vivekanandhan | 134 | 73 | 47 | 95 | 23 | 435 |
All Works
Login with ORCID to disown or claim papers
Loading papers...